Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection

PURPOSE: In some patients with Hodgkin lymphoma (HL), proton beam therapy (PBT) may reduce the risk of radiation-related cardiovascular disease (CVD) and second cancers (SC) compared with photon radiation therapy (RT). Our aim was to identify patients who benefit the most from PBT in terms of predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ntentas, Georgios, Dedeckova, Katerina, Andrlik, Michal, Aznar, Marianne C., Shakir, Rebecca, Ramroth, Johanna, Begum, Rubina, Kubeš, Jiří, Darby, Sarah C., Mikhaeel, N. George, Cutter, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier, Inc 2022
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865523/
https://www.ncbi.nlm.nih.gov/pubmed/34762970
http://dx.doi.org/10.1016/j.ijrobp.2021.10.151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865523/
https://www.ncbi.nlm.nih.gov/pubmed/34762970
http://dx.doi.org/10.1016/j.ijrobp.2021.10.151

Ejemplares similares